Dr Reddys Laboratories (RDY) Cash & Equivalents (2009 - 2026)
Dr Reddys Laboratories' Cash & Equivalents came in at $138.41 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), up 23.9% from $111.67 million a year earlier and up 17.1% from the prior quarter.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Cash & Equivalents (2009 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Dr Reddys Laboratories' Cash & Equivalents was $164 million, down 4.7% from FY2025.
- Cash & Equivalents carries a five-year compound annual growth rate of -4.2% (FY2021 to FY2026).
- Going back by fiscal year, Cash & Equivalents was $172 million in FY2025 (+102.4%), $85 million in FY2024 (+21.4%), $70 million in FY2023 (-64.3%) and $196 million in FY2022 (-3.4%).
- The five-year range for quarterly Cash & Equivalents is $58.87 million (fiscal Q1 2025) to $295.25 million (fiscal Q3 2022).
- Year-over-year, Cash & Equivalents increased in six of the last eight quarters, with growth averaging 37.1%.
- The fastest year-over-year change in Cash & Equivalents over five years came in fiscal Q3 2022 (growth of 399.7%), and the weakest in fiscal Q3 2023 (a decline of 74.4%).
- Business Quant data shows RDY's Cash & Equivalents at $118.2 million (Q1 2027), $162.87 million (Q4 2026) and $207.83 million (Q3 2026) in the three fiscal quarters before Q2 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,246.80 Bn | 1,220.42 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 674.35 Bn | 594.21 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 517.12 Bn | 485.13 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.12 Bn | 327.06 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 315.40 Bn | 288.64 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 292.28 Bn | 266.18 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 250.93 Bn | 202.58 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 209.69 Bn | 184.80 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.04 Bn | 114.40 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Dr Reddys Laboratories | 12.44 Bn | 11.78 Bn | 472.93 Mn | 138.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 138.41 Mn |
| Jun 30, 2026 | 118.20 Mn |
| Mar 31, 2026 | 162.87 Mn |
| Dec 31, 2025 | 207.83 Mn |
| Sep 30, 2025 | 111.67 Mn |
| Jun 30, 2025 | 105.37 Mn |
| Mar 31, 2025 | 171.31 Mn |
| Dec 31, 2024 | 151.91 Mn |
| Sep 30, 2024 | 135.34 Mn |
| Jun 30, 2024 | 58.87 Mn |
| Mar 31, 2024 | 85.22 Mn |
| Dec 31, 2023 | 91.55 Mn |
| Sep 30, 2023 | 162.74 Mn |
| Jun 30, 2023 | 88.07 Mn |
| Mar 31, 2023 | 70.39 Mn |
| Dec 31, 2022 | 75.56 Mn |
| Sep 30, 2022 | 111.63 Mn |
| Jun 30, 2022 | 79.81 Mn |
| Mar 31, 2022 | 195.86 Mn |
| Dec 31, 2021 | 295.25 Mn |
API Access
Dr Reddys Laboratories Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();